Visiomed Group S.A. (ALVMG.PA)

Visiomed Group S.A. (ALVMG.PA) — VMCI valuation read

ALVMG.PA prints VMCI 45/100 inside the Healthcare sector, where the median sits at 50. The 5-point below-median delta is the cleanest single-number summary of Visiomed Group S.A.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On ALVMG.PA, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** ALVMG.PA trades at 18.0x earnings, 0% above the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 2.8x is the rate-sensitivity line to watch; that is the risk line for Visiomed Group S.A. on the trailing financials.

ALVMG.PA fell 2.4% over the trailing 7 days, with a -11.0% read on a 30-day basis.